SFS
ZYNE

Sowell Financial Services’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Sowell Financial Services’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-45
Closed – – 2965
2021
Q1 		$0 Sell
45
-12,535
-100% -$56.8K ﹤0.01% 3361
2020
Q4 		$42K Buy
12,580
+12,500
+15,625% +$47.5K ﹤0.01% 1466
2020
Q3 		$0 Sell
80
-2,283
-97% -$8.39K ﹤0.01% 2763
2020
Q2 		$8K Buy
2,363
+2,283
+2,854% +$10.8K ﹤0.01% 1786
2020
Q1 		$0 Hold
80
– – ﹤0.01% 2761
2019
Q4 		$0 Hold
80
– – ﹤0.01% 2698
2019
Q3 		$1K Buy
+80
New +$902 ﹤0.01% 2346

Other funds holding ZYNE

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sowell Financial Services's ZYNE Position: Q2 2021 in Review

Sowell Financial Services sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q2 2021, closing a stake of 45 shares.

Sowell Financial Services first reported a position in ZYNE in Q3 2019 and held it in 7 quarters. The position peaked at $42K in Q4 2020. 65 funds tracked by Wall St. Rank hold ZYNE as of Q2 2021.

  • Sowell Financial Services reported no remaining Zynerba Pharmaceuticals, Inc position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 45 Zynerba Pharmaceuticals, Inc shares in Q2 2021.
  • Sowell Financial Services first reported a position in Zynerba Pharmaceuticals, Inc in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's Zynerba Pharmaceuticals, Inc position peaked at $42K in Q4 2020.
  • 65 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.